Cargando…
Ribavirin : biochemistry, clinical applications and potential side effects /
Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
[Hauppauge] New York :
Nova Biomedical,
[2013]
|
| Colección: | Pharmacology-research, safety testing, and regulation series.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn862134874 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 130729t20132013nyua ob 001 0 eng | ||
| 010 | |a 2020679940 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d N$T |d OCLCF |d ICA |d AGLDB |d VTS |d AU@ |d STF |d YDXCP |d OCLCO |d AJS |d OCLCO |d OCLCQ |d OCLCO | ||
| 020 | |a 9781628088144 |q (ebook) | ||
| 020 | |a 1628088141 | ||
| 020 | |z 9781628088137 |q (paperback) | ||
| 020 | |z 1628088133 | ||
| 029 | 1 | |a DEBBG |b BV042795576 | |
| 029 | 1 | |a DEBBG |b BV043960485 | |
| 029 | 1 | |a DEBSZ |b 481276874 | |
| 035 | |a (OCoLC)862134874 | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RS431.A66 |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 0 | |a 615.7/924 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Ribavirin : |b biochemistry, clinical applications and potential side effects / |c Joris Buskirk, editor. |
| 264 | 1 | |a [Hauppauge] New York : |b Nova Biomedical, |c [2013] | |
| 264 | 4 | |c Ã2013 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Pharmacology-research, safety testing and regulation | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a RIBAVIRIN. BIOCHEMISTRY, CLINICAL APPLICATIONS AND POTENTIAL SIDE EFFECTS; RIBAVIRIN. BIOCHEMISTRY, CLINICAL APPLICATIONS AND POTENTIAL SIDE EFFECTS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Optimizing Ribavirin Usefor the Treatment of Hepatitis C; Abstract; Introduction; Hepatitis C (HCV); The Evolution of HCV Treatment -The Importance of RBV; Why Was New Treatment Discovery for HCV Hampered?; The Direct Acting Antiviral (DAA) Era; Pharmacokinetics of RBV; RBV -Induced Hemolytic Anemia; Identification of the Inosine Triphosphatase Gene. | |
| 505 | 8 | |a Mechanism of Action of Ribavirin in HCVThe Importance of RBV Adherence; The Importance of Pill Burden and Dosing Frequency on Medication Adherence; RBV QD vs. BID Dosing; Summary of Once Daily DAA trials; Conclusion; References; Chapter 2: Ribavirin and its Great Potentials in Infectious Diseases; Abstract; Introduction; Structure; History; Metabolism; Mechanism of Action; Spectrum of Action; Anticancer Role; Ribavirin Derivatives; Ribavirin and HCV; Ribavirin Side Effects; References; Chapter 3: Antiviral Actions of Ribavirin; Abstract; Introduction. | |
| 505 | 8 | |a 1. Biochemistry, Pharmacokinetics and Mechanism of Action2. Clinical Applications; 3. Potential Side Effects; References; Chapter 4: A Novel Prediction Method for the Responsiveness of Hepatitis C Patients to Drug Treatment; Abstract; 1. Introduction; 2. Materials and Methods; 3. Results and discussion; Acknowledgments; References; Chapter 5: Ribavirin Intolerable Cough during HCV Combination Therapy Can Be Overcome by Nitazoxanide Replacement; Abstract; Introduction; Case Presentation; Discussion; Conclusion; References; Index. | |
| 520 | |a Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimizing Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C pat. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Ribavirin. | |
| 650 | 0 | |a Antiviral agents. | |
| 650 | 2 | |a Ribavirin | |
| 650 | 2 | |a Antiviral Agents | |
| 650 | 6 | |a Ribavirine. | |
| 650 | 6 | |a Antiviraux. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Antiviral agents |2 fast | |
| 650 | 7 | |a Ribavirin |2 fast | |
| 700 | 1 | |a Buskirk, Joris, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Ribavirin. |d [Hauppauge] New York : Nova Biomedical, [2013] |z 9781628088137 |w (DLC) 2013946511 |
| 830 | 0 | |a Pharmacology-research, safety testing, and regulation series. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=650669 |z Texto completo |
| 938 | |a EBSCOhost |b EBSC |n 650669 | ||
| 938 | |a YBP Library Services |b YANK |n 10927496 | ||
| 994 | |a 92 |b IZTAP | ||